Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging
Conditions
- Nephrogenic Fibrosing Dermopathy
Interventions
- DRUG: Gadodiamide
- DRUG: Gadoteric Acid Meglumine Salt
Sponsor
The Central Hospital of Lishui City
Collaborators